Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.560
+0.090 (6.12%)
At close: Apr 14, 2026, 4:00 PM EDT
1.550
-0.010 (-0.64%)
After-hours: Apr 14, 2026, 5:40 PM EDT
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $417.89 million as of April 14, 2026. Its market cap has decreased by -8.34% in one year.
Market Cap
417.89M
Enterprise Value
431.83M
1-Year Change
-8.34%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $417.89M, a decrease of -14.38%. That is a compound annual growth rate of -1.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 393.80M | -7.82% |
| Dec 31, 2025 | 427.20M | 3.06% |
| Dec 31, 2024 | 414.50M | 77.44% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 718.51M |
| Ironwood Pharmaceuticals | 591.90M |
| Esperion Therapeutics | 557.28M |
| Aquestive Therapeutics | 497.94M |
| Kamada | 492.69M |
| Emergent BioSolutions | 411.09M |
| Canopy Growth | 404.86M |
| SIGA Technologies | 312.37M |